Skip to main content
Log in

Localization of tenascin in human skin wounds —An immunohistochemical study

  • Original Articles
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Summary

A total of 56 surgically treated human skin wounds with a wound age between 8h and 7 months were investigated. Tenascin was visualized by immunohistochemistry and appeared first in the wound area pericellularly around fibroblastic cells approximately 2 days after wounding. A network-like interstitial positive staining pattern was first detectable in 3-day-old skin wounds. In all wounds with an age of 5 days or more, intensive reactivity for tenascin could be observed in the lesional area (dermal-epidermal junction, wound edge, areas of bleeding). In wounds with an age of more than approximately 1.5 months no positive staining occurred in the scar tissue. In conclusion, for forensic purposes, positive staining for tenascin restricted to the pericellular area of fibroblastic cells indicates a wound age of at least 2 days. Network-like structures appear after approximately 3 days or more. Since tenascin seems to be regularly detectable in skin wounds older than 5 days, the lack of a positive reaction in a sufficient number of specimens indicates a wound age of less than 5 days. The lack of a positive reaction in the granulation tissue of wounds with advanced wound age indicates a survival time of more than about 1.5 months, but a positive staining in older wounds cannot be excluded.

Zusammenfassung

In 56 chirurgisch versorgten menschlichen Hautwunden mit einem Wundalter zwischen 8 Stunden und 7 Monaten wurde Tenascin immunhistochemisch dargestellt. Erstmals war Tenascin in einer 2 Tage alten Wunde perizellulär um Fibroblasten nachweisbar. Netzwerk-artige, positiv reagierende Strukturen traten im Wundgebiet frühestens nach einer Überlebenszeit von 3 Tagen auf und waren in Hautwunden, die älter als 4 Tage waren, regelmäßig anzutreffen. Mit zunehmendem Wundalter war eine Abnahme der Reaktivität für Tenascin im Granulationsgewebe feststellbar und in den ältesten untersuchten Hautwunden (Wundalter 2,5 bzw. 7 Monate) war kein Tenascin mehr außerhalb des üblicherweise anfärbbaren Strukturen zu beobachten. Der perizelluläre Nachweis von Tenascin belegt somit ein Wundalter von mindestens ca. 2 Tagen, netzwerkartige, positiv anfärbbare Strukturen im Wundgebiet ein Wundalter von mindestens ca. 3 Tagen. Die regelmäßige Nachweisbarkeit von Tenascin ab einem Wundalter von ca. 5 Tagen gibt bei einer ausreichenden Anzahl von untersuchten Präparaten und Fehlen einer entsprechenden Reaktion Hinweise auf eine Überlebenszeit von unter 5 Tagen. Mit zunehmendem Wundalter sinkt die Reaktivität des Granulationsgewebes für Tenascin und eine positive Reaktion deutet auf eine Überlebenszeit bis ca. 1,5 Monate hin, eine längere Nachweisbarkeit kann jedoch nicht ausgeschlossen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aufderheide E, Ekblom P (1988) Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms and dependence on epithelial-mesenchymal interactions. J Cell Biol 107:2341–2349

    PubMed  Google Scholar 

  2. Aufderheide E, Chiquet-Ehrismann R, Ekblom P (1987) Epithelial-mesenchymal interactions in the developing kidney lead to the expression of tenascin in the mesenchyme. J Cell Biol 105:599–608

    PubMed  Google Scholar 

  3. Berg S (1975) Vitale Reaktionen and Zeitschätzungen. In: Mueller B (Hrsg) Gerichtliche Medizin, Bd. 1. Springer, Berlin Heidelberg New York, pp 326–340

    Google Scholar 

  4. Betz P, Nerlich A, Wilske J, Tübel J, Wiest I, Penning R, Eisenmenger W (1992) Immunohistochemical localization of fibronectin as a tool for the age determination of human skin wounds. Int J Leg Med 105:21–26

    Google Scholar 

  5. Bourdon MA, Ruoslahti E (1989) Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 108:1149–1155

    PubMed  Google Scholar 

  6. Bronner-Fraser M (1988) Distribution and function of tenascin during cranial neural crest development in the chick. J Neurosci Res 21:135–147

    PubMed  Google Scholar 

  7. Chiquet-Ehrismann R (1990) What distinguishes tenascin from fibronectin? FASEB 14:2598–2604

    Google Scholar 

  8. Chiquet M, Fambrough DM (1984) Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 98:1926–1936

    PubMed  Google Scholar 

  9. Chiquet M, Fambrough DM (1984) Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol 98:1937–1946

    PubMed  Google Scholar 

  10. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M (1988) Tenascin interferes with fibronectin action. Cell 53:383–390

    PubMed  Google Scholar 

  11. Chuong CM, Chen HH (1991) Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol 138:427–440

    PubMed  Google Scholar 

  12. Chuong CM, Crossin KL, Edelman GM (1987) Sequential expression and differential functions of multiple adhesion molecules during the formation of cerebellar cortical layers. J Cell Biol 104:331–342

    PubMed  Google Scholar 

  13. Grinnell F, Billingham RE, Burgess L (1981) Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 76:181–189

    PubMed  Google Scholar 

  14. Hsu SM, Raine L, Fanger H (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radio immunoassay antibodies Am J Clin Pathol 75:734–739

    PubMed  Google Scholar 

  15. Inaguma Y, Kusakabe M, Mackie EJ, Pearson CA, Chiquet-Ehrismann R, Sakakura T (1988) Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol 128:245–255

    PubMed  Google Scholar 

  16. Jones FS, Burgoon MP, Hoffmann S, Crossin KL, Cunningham BA, Edelman GM (1988) A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA 85:2186–2190

    PubMed  Google Scholar 

  17. Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M (1985) The J1 glycoprotein: a novel nervous system cell adhesion molecule for the L2/HNK-1 family. Nature 316:146–148

    PubMed  Google Scholar 

  18. Lightner VA, Erickson HP (1990) Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 95:263–277

    PubMed  Google Scholar 

  19. Lightner VA, Gumkowski F, Bigner DD, Erickson HP (1989) Ten ascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol 108:2483–2493

    PubMed  Google Scholar 

  20. Mackie EJ, Thesleff I, Chiquet-Ehrismann R (1987) Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 105:2569–2579

    PubMed  Google Scholar 

  21. Mackie EJ, Halfter W, Liverani D (1988) Induction of tenascin in healing wounds. J Cell Biol 107:2757–2767

    PubMed  Google Scholar 

  22. Maier A, Mayne R (1987) Distribution of connective tissue proteins in chick muscle spindles as revealed by monoclonal antibodies: a unique distribution of brachionectin/tenascin. Am J Anat 180:226–236

    PubMed  Google Scholar 

  23. Murakami R, Yamaoka I, Sakakura T (1989) Appearance of tenascin in healing skin of the mouse: possible involvement in seaming of wound tissues. Int J Dev Biol 33: 439–444

    PubMed  Google Scholar 

  24. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R (1988) Tenascin: cDNA cloning and induction by TGF-B. EMBO J 7:2677–2981

    Google Scholar 

  25. Ruegg CR, Chiquet-Ehrismann R, Alkan SS (1989) Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 86:7437–7441

    PubMed  Google Scholar 

  26. Stamp GWH (189) Tenascin distribution in basal cell carcinomas. J Pathol t59:225–229 27. Thesleff I, Mackie I, Vainio S, Chiquet-Erismann R (1987) Changes in the distribution of tenascin during tooth development. Development 101:289–296

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Betz, P., Nerlich, A., Tübel, J. et al. Localization of tenascin in human skin wounds —An immunohistochemical study. Int J Leg Med 105, 325–328 (1993). https://doi.org/10.1007/BF01222116

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01222116

Key words

Schlüsselwörter

Navigation